Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral Radiculopathy
NCT ID: NCT00159705
Last Updated: 2021-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
276 participants
INTERVENTIONAL
2005-04-30
2007-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
NCT00219544
Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00143156
Pregabalin Peripheral Neuropathic Pain Study
NCT00141219
Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain
NCT01455415
Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study
NCT01298466
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pregabalin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Radicular pain must be present for at least 3 months and pain stable for at least 4 weeks.
Exclusion Criteria
* Epidural injection for lumbo-sacral radiculopathy within previous 6 weeks and/or anticipated need for treatment with opioid analgesics, anti-epileptic medications or tricyclic antidepressants to alleviate pain due to lumbo-sacral radiculopathy during the course of the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Phoenix, Arizona, United States
Pfizer Investigational Site
Denver, Colorado, United States
Pfizer Investigational Site
Plantation, Florida, United States
Pfizer Investigational Site
Chicago, Illinois, United States
Pfizer Investigational Site
Indianapolis, Indiana, United States
Pfizer Investigational Site
Boston, Massachusetts, United States
Pfizer Investigational Site
Independence, Missouri, United States
Pfizer Investigational Site
Rochester, New York, United States
Pfizer Investigational Site
Valley Stream, New York, United States
Pfizer Investigational Site
Portland, Oregon, United States
Pfizer Investigational Site
Allentown, Pennsylvania, United States
Pfizer Investigational Site
Allentown, Pennsylvania, United States
Pfizer Investigational Site
Bethlehem, Pennsylvania, United States
Pfizer Investigational Site
Edegem, , Belgium
Pfizer Investigational Site
Eeklo, , Belgium
Pfizer Investigational Site
Genk, , Belgium
Pfizer Investigational Site
Pellenberg, , Belgium
Pfizer Investigational Site
Vancouver, British Columbia, Canada
Pfizer Investigational Site
Hawkesbury, Ontario, Canada
Pfizer Investigational Site
Kingston, Ontario, Canada
Pfizer Investigational Site
London, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Fleurimont, Quebec, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Bremen, , Germany
Pfizer Investigational Site
Eichstätt, , Germany
Pfizer Investigational Site
Göppingen, , Germany
Pfizer Investigational Site
Kiel, , Germany
Pfizer Investigational Site
München, , Germany
Pfizer Investigational Site
Nuremberg, , Germany
Pfizer Investigational Site
Wiesbaden, , Germany
Pfizer Investigational Site
Localita' Cravino, Pavia, Italy
Pfizer Investigational Site
Imperia, , Italy
Pfizer Investigational Site
Milan, , Italy
Pfizer Investigational Site
Napoli, , Italy
Pfizer Investigational Site
Pavia, , Italy
Pfizer Investigational Site
Roma, , Italy
Pfizer Investigational Site
Badalona, Barcelona, Spain
Pfizer Investigational Site
Granada, , Spain
Pfizer Investigational Site
Madrid, , Spain
Pfizer Investigational Site
Seville, , Spain
Pfizer Investigational Site
Seville, , Spain
Pfizer Investigational Site
Valencia, , Spain
Pfizer Investigational Site
Gothenburg, , Sweden
Pfizer Investigational Site
Lidingö, , Sweden
Pfizer Investigational Site
Linköping, , Sweden
Pfizer Investigational Site
Luleå, , Sweden
Pfizer Investigational Site
Skellefteå, , Sweden
Pfizer Investigational Site
Stockholm, , Sweden
Pfizer Investigational Site
Inciraltı, İzmir, Turkey (Türkiye)
Pfizer Investigational Site
Ankara, , Turkey (Türkiye)
Pfizer Investigational Site
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A0081007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.